The Cancer Letter Archives
The Cancer Letter was founded in 1973, two years after Congress passed the National Cancer Act of 1971. These archives represent the first 40 years of The Cancer Letter, which is published weekly.
February 25, 2005
- Tarceva Added To Gemcitabine Improves Pancreatic Cancer Survival, Study Finds
- Finasteride Could Save Many Years Of Life If Widely Used For Prostate Cancer Prevention
- Center Studies Prevention For Endometrial Cancer
- Fruit, Vegetables Don’t Prevent Protect Against Breast Cancer
- Men With PSA Of 7 Or Higher More Likely To Have Biopsy
- Northwestern To Test Method To Detect Colon Cancer
- Treatment Doesn’t Always Follow Recommendations
- Transplant Is Viable Option For HIV+ Patients, Study Finds
- QOL Of Young Survivors Equal To Other Children
- High-Dose Chemo Can Cure Rare Pediatric Brain Tumor
- MRI Predicts If Chemo Working In Preoperative Therapy
- Clinical Trials Approved By NCI’s CTEP Listed
March 04, 2005
- FDA claims news coverage violated privacy of applicants for oncology job.
- FDA’s Kweder cites Society of Professional Journalists’ Code of Ethics–incorrectly, SPJ says.
- Also in this 8-page issue: American Legacy Foundation calls Time Inc. a “hero” of tobacco control, but antismoking activists see villain. Time Inc. and parent Time Warner hasn’t made progress in reducing tobacco advertising in magazines, movies, researchers say.
March 11, 2005
- NCI Board of Scientific Advisors rejects the Institute’s $89 million proteomics research plan.
- Proof of principle needed before launching “big science” program, advisors say.
- Also in this 12-page issue: NCI’s Lance Liotta and FDA’s Emanuel Petricoin to move to George Mason University.
- Zvi Fuks of Memorial Sloan-Kettering arrested and charged with securities fraud related to sale of ImClone stock.
March 18, 2005
- NCI advisory panel recommends funding a 10-year Human Cancer Genome Project with $1.35 billion in new money.
- Scientists should lobby Congress to support the project, Broad Institute Director Eric Lander says.
- FDA says official spoke on own behalf in admonition to The Cancer Letter. Association of Health Care Journalists asks FDA official to rescind her rebuke.
April 08, 2005
- Ethics rules slammed by NIH scientists, institute directors, societies, Senators.
- NCI director says rules hurt retention, recruitment, cites Liotta’s departure.
- NIH institute directors, in response to question from Sen. Arlen Specter, say Bush Administration’s stem cell research policy is harmful to NIH leadership in science.